 Therefore this observational registry has been designed for the clinical evaluation of the Orsiro LESS in diabetic subjects Diabetic patients type 1 or 2 requiring coronary revascularization with Drug Eluting Stents DES. Results will contribute to the collection of clinical evidence for the clinical performance and safety of the Orsiro Drug Eluting Stent System in daily clinical practice. 